We use methods in decision sciences, health services research, and epidemiology to understand what works, for whom, and at what cost, with a focus on mental and behavioral health.
Learn more about our members.
This study used decision-analytic modeling to compare the health effects, costs, and cost-effectiveness of three treatments for opioid use disorder during pregnancy. We found that split-dose methadone generated the most health benefits (measured in terms of quality-adjusted life years), but buprenorphine was the most cost-effective option.
Published in the Journal of Substance Abuse & Addiction Treatment (link). Co-authored with Ruth Jeminiwa and Dennis Hand from Thomas Jefferson University.